Uri Baruch Named as New Vice President and Managing Director of Oval Medical Technologies Ltd. and Cambridge Pharma Ltd. (SMC Ltd. European division)
Cambridge, United Kingdom – SMC Ltd., a global medical device and pharmaceutical services company, is proud to announce the appointment of Uri Baruch as the new Vice President and Managing director of its European Division, which includes Oval Medical Technologies and Cambridge Pharma Ltd. (CPL), effective immediately.
Uri brings with him a wealth of experience and a proven track record of success in the pharmaceutical industry. He has held several key leadership positions, including over 10 years at the Cambridge Design Partnership. Throughout his career, Uri has demonstrated an unwavering commitment to patient care, and a keen understanding of the complex regulatory landscape that governs the industry.
In his new role at SMC Ltd. Uri will be responsible for overseeing all aspects of SMC Ltd.’s European division which specialises in pharmaceutical services including autoinjector design and development at Oval Medical Technologies and pharmaceutical sterile filling at CPL.
“I am honored and excited to join SMC Ltd. as the new VP and MD of SMC’s European division,” said Uri Baruch. “The combination of SMC production, CPL sterile filling, and Oval’s novel autoinjector design is a unique offering which can add considerable value to our customers. I look forward to working with our talented and passionate employees, who like me, truly believe in innovating to improve patients’ lives.”
“Uri’s appointment comes at an important time for SMC as we continue to expand our presence in the pharmaceutical industry and pursue new opportunities for growth. We are excited to welcome him to the SMC team,” said SMC’s CEO Chetan N. Patel. “Uri will continue the great work that has been done by our European teams to date and his deep industry expertise and passion for advancing patient care make him the perfect fit to lead the SMC Europe teams. We are confident that he will help us achieve our goals and drive continued growth for our Company.”
For further information contact:
Oval Medical Technologies Ltd. and Cambridge Pharma Ltd.
Tim Holden, Director of BD and Licensing
Unit 3, Enterprise 3930
Cambridge Research Park
Beach Drive, Waterbeach
CB25 9PE, UK
+44 1223 736 220
Dan Achtor, Senior Director of Marketing
330 SMC Drive
Somerset, WI 54025
+1 (602) 300 2854